As a real estate partner to many of the world’s leading biotech firms and research institutions, we’re thrilled to see the FDA complete its first AI-assisted scientific review. This represents a transformative moment for life science innovation, with the potential to shorten the timeline and lower the cost of drug approvals. This achievement signals a bold new era for the industry—one that our tenants are actively shaping. As their research accelerates and their needs evolve, we’re proud to provide the state-of-the-art lab space that supports their groundbreaking discoveries. Read the full FDA announcement here: https://lnkd.in/e45zBxJF #LifeScienceRealEstate #LabRealEstate #FDA #Biotech #ScientificReview
